Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Icahn School of Medicine at Mount Sinai · Mount Sinai Hospital
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
688
total citations
- FWCI
- 28.99
- Percentile
- 100%
- References
- 26
Citations per year
Authors
7- MAMarije aan het RotCorresponding
Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital
- KAKatherine A. Collins
Icahn School of Medicine at Mount Sinai
- JWJames W. Murrough
Icahn School of Medicine at Mount Sinai
- AMAndrew M. Perez
Icahn School of Medicine at Mount Sinai
- DLDavid L. Reich
Icahn School of Medicine at Mount Sinai
Topics & keywords
Topics
Keywords
- Ketamine
- Tolerability
- Medicine
- Anesthesia
- Treatment-resistant depression
- Adverse effect
- Antidepressant
- Depression (economics)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.